A CKD mouse model fed iodomethylcholine, an indirect TMAO inhibitor that suppresses TMA generation, exhibited reduced levels of renal injury markers such as urea, fibroblast growth factor 23 (FGF23), and cystatin C [19]. The gene discussed is FGF23; the disease is chronic kidney disease.